LISATA THERAPEUTICS, INC. Proceeds from Issuance of Debt
LISATA THERAPEUTICS, INC. (LSTA) reported Proceeds from Issuance of Debt of $11.70 million for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2016-05-05
- LISATA THERAPEUTICS, INC. proceeds from issuance of debt for the quarter ending 2016-03-31 was $11.70M, a 0.00% change year-over-year.
- LISATA THERAPEUTICS, INC. proceeds from issuance of debt for the quarter ending 2015-12-31 was -$400.00K.
- LISATA THERAPEUTICS, INC. proceeds from issuance of debt for the quarter ending 2015-09-30 was $0.00.
- LISATA THERAPEUTICS, INC. proceeds from issuance of debt for the quarter ending 2015-06-30 was $0.00.
- LISATA THERAPEUTICS, INC. proceeds from issuance of debt for fiscal 2015 was $11.30M, a 0.00% change from fiscal 2014.
- LISATA THERAPEUTICS, INC. proceeds from issuance of debt for fiscal 2014 was $11.30M.
| Period end | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 9 month | Proceeds from Issuance of Debt 12 month |
|---|---|---|---|---|
| 2016-03-31 | $11.70M 10-Q · filed 2016-05-05 | $11.30M derived: sum of 2 quarters · filed 2016-05-05 | $11.30M derived: sum of 3 quarters · filed 2016-05-05 | $11.30M derived: sum of 4 quarters · filed 2016-05-05 |
| 2015-12-31 | -$400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$400.00K derived: sum of 2 quarters · filed 2016-03-15 | -$400.00K derived: sum of 3 quarters · filed 2016-03-15 | $11.30M 10-K · filed 2016-03-15 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $0.00 derived: sum of 2 quarters · filed 2015-11-05 | $11.70M 10-Q · filed 2015-11-05 | $11.30M derived: sum of 4 quarters · filed 2015-11-05 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $11.70M 10-Q · filed 2015-08-06 | $11.30M derived: sum of 3 quarters · filed 2015-08-06 | |
| 2015-03-31 | $11.70M 10-Q · filed 2015-05-06 | $11.30M derived: sum of 2 quarters · filed 2015-05-06 | ||
| 2014-12-31 | -$400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $11.30M 10-K · filed 2015-03-02 | ||
| 2014-09-30 | $11.70M 10-Q · filed 2014-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |